Abstract:14Intrinsically photosensitive retinal ganglion cells (ipRGCs) are rare mammalian photoreceptors 15 essential for non-image-forming vision functions, such as circadian photoentrainment and the 16 pupillary light reflex. They comprise multiple subtypes distinguishable by morphology, physiology, 17 projections, and levels of expression of melanopsin (Opn4), their photopigment. The molecular 18 programs that differentiate ipRGCs from other ganglion cells and ipRGC subtypes from one 19 another remain elusive. Here… Show more
“…The OPN4‐GFP transgenic mouse line has been shown to label ipRGCs. This line, however, is reported to only visualize M1, M2, and M3 as the amount of OPN4 expression varies between the ipRGC subgroups (Berg et al., 2018). OPN4‐GFP‐positive cells colocalized with RBPMS staining (Figure 4c), and 17% ± 0% of OPN4‐GFP cells were positively labeled for Arl13b and 54% ± 7% for AC3 (Figure 4d).…”
Section: Resultsmentioning
confidence: 99%
“…C57BL/6J mice were purchased from The Jackson Laboratories (stock # 000664). Genetically defined RGC transgenic mice Trhr‐GFP (Gong et al., 2003; Rivlin‐Etzion et al., 2011), Hoxd10‐GFP (Dhande et al., 2013), OPN4‐GFP (Berg et al., 2018), and Cdh3‐GFP (Osterhout et al., 2011; Quattrochi et al., 2019) were a gift from Dr. Andrew Huberman's Lab (Stanford). Mice were kept under a 12‐h light/dark cycle and had free access to food and water.…”
Loss of retinal ganglion cells (RGCs) underlies several forms of retinal disease including glaucomatous optic neuropathy, a leading cause of irreversible blindness. Several rare genetic disorders associated with cilia dysfunction have retinal degeneration as a clinical hallmark. Much of the focus of ciliopathy associated blindness is on the connecting cilium of photoreceptors; however, RGCs also possess primary cilia. It is unclear what roles RGC cilia play, what proteins and signaling machinery localize to RGC cilia, or how RGC cilia are differentiated across the subtypes of RGCs. To better understand these questions, we assessed the presence or absence of a prototypical cilia marker Arl13b and a widely distributed neuronal cilia marker AC3 in different subtypes of mouse RGCs. Interestingly, not all RGC subtype cilia are the same and there are significant differences even among these standard cilia markers. Alpha-RGCs positive for osteopontin, calretinin, and SMI32 primarily possess AC3-positive cilia. Directionally selective RGCs that are CART positive or Trhr positive localize either Arl13b or AC3, respectively, in cilia. Intrinsically photosensitive RGCs differentially localize Arl13b and AC3based on melanopsin expression. Taken together, we characterized the localization of gold standard cilia markers in different subtypes of RGCs and conclude that cilia within RGC subtypes may be differentially organized. Future studies aimed at understanding RGC cilia function will require a fundamental ability to observe the cilia across subtypes as their signaling protein composition is elucidated. A comprehensive understanding of RGC cilia may reveal opportunities to understanding how their dysfunction leads to retinal degeneration.
“…The OPN4‐GFP transgenic mouse line has been shown to label ipRGCs. This line, however, is reported to only visualize M1, M2, and M3 as the amount of OPN4 expression varies between the ipRGC subgroups (Berg et al., 2018). OPN4‐GFP‐positive cells colocalized with RBPMS staining (Figure 4c), and 17% ± 0% of OPN4‐GFP cells were positively labeled for Arl13b and 54% ± 7% for AC3 (Figure 4d).…”
Section: Resultsmentioning
confidence: 99%
“…C57BL/6J mice were purchased from The Jackson Laboratories (stock # 000664). Genetically defined RGC transgenic mice Trhr‐GFP (Gong et al., 2003; Rivlin‐Etzion et al., 2011), Hoxd10‐GFP (Dhande et al., 2013), OPN4‐GFP (Berg et al., 2018), and Cdh3‐GFP (Osterhout et al., 2011; Quattrochi et al., 2019) were a gift from Dr. Andrew Huberman's Lab (Stanford). Mice were kept under a 12‐h light/dark cycle and had free access to food and water.…”
Loss of retinal ganglion cells (RGCs) underlies several forms of retinal disease including glaucomatous optic neuropathy, a leading cause of irreversible blindness. Several rare genetic disorders associated with cilia dysfunction have retinal degeneration as a clinical hallmark. Much of the focus of ciliopathy associated blindness is on the connecting cilium of photoreceptors; however, RGCs also possess primary cilia. It is unclear what roles RGC cilia play, what proteins and signaling machinery localize to RGC cilia, or how RGC cilia are differentiated across the subtypes of RGCs. To better understand these questions, we assessed the presence or absence of a prototypical cilia marker Arl13b and a widely distributed neuronal cilia marker AC3 in different subtypes of mouse RGCs. Interestingly, not all RGC subtype cilia are the same and there are significant differences even among these standard cilia markers. Alpha-RGCs positive for osteopontin, calretinin, and SMI32 primarily possess AC3-positive cilia. Directionally selective RGCs that are CART positive or Trhr positive localize either Arl13b or AC3, respectively, in cilia. Intrinsically photosensitive RGCs differentially localize Arl13b and AC3based on melanopsin expression. Taken together, we characterized the localization of gold standard cilia markers in different subtypes of RGCs and conclude that cilia within RGC subtypes may be differentially organized. Future studies aimed at understanding RGC cilia function will require a fundamental ability to observe the cilia across subtypes as their signaling protein composition is elucidated. A comprehensive understanding of RGC cilia may reveal opportunities to understanding how their dysfunction leads to retinal degeneration.
“…Our previous studies identified 4 T-RGC and 4 F-RGC types, but this new approach revealed a fifth type within each subclass (C9 and C32, respectively; Figures 2C, 2D, and S2B). For ipRGCs, we discovered markers for M1 (C33 and 40), M2 (C31), and M4 (C43) types, including some that divide M1-RGCs (identified by high levels of Opn4 and expression of Adcyap1; Hannibal et al, 2002) into two types (M1a, M1b), as well as an additional cluster (C22) that could correspond to the morphologically and physiologically characterized M3, M5, or M6 types (Figure 2E) (Quattrochi et al, 2019;Schmidt et al, 2011;Stabio et al, 2018;Berg et al, 2019). For ooDSGCs, most of which are Cartpt+, we identified the nasal-preferring type (N-ooDSGC) by expression of Mmp17, but only a single cluster (C16) expressed Col25a1, a marker of both D-and V-ooDSGCs (Kay et al, 2011).…”
Section: Transcriptome-assisted Division Of Rgcs Into Subclassesmentioning
Neuronal types in the central nervous system differ dramatically in their resilience to injury or other insults. Here we studied the selective resilience of mouse retinal ganglion cells (RGCs) following optic nerve crush (ONC), which severs their axons and leads to death of $80% of RGCs within 2 weeks. To identify expression programs associated with differential resilience, we first used single-cell RNA-seq (scRNA-seq) to generate a comprehensive molecular atlas of 46 RGC types in adult retina. We then tracked their survival after ONC; characterized transcriptomic, physiological, and morphological changes that preceded degeneration; and identified genes selectively expressed by each type. Finally, using loss-and gain-of-function assays in vivo, we showed that manipulating some of these genes improved neuronal survival and axon regeneration following ONC. This study provides a systematic framework for parsing type-specific responses to injury and demonstrates that differential gene expression can be used to reveal molecular targets for intervention.
“…For instance, M1 ipRGCs can be distinguished by expression of adenylate cyclase activating polypeptide 1 (Adcyap1) and the absence of the neuromedin B (Nmb) gene while an additional M1 type can be identified by the co-expression of Adcyap1 and Nmb (Tran et al, 2019). M2 subtype can be identified by the presence of Spp1 and T-box transcription factor (Tbx20), known to be selectively expressed in ipRGCs and greatly enriched in M2 over other ipRGC types (Berg et al, 2019). M4/alpha ON-S RGCs were found to be distinguished by the expression of Spp1 and interleukin one receptor accessory protein like 2 (Il1rapl2) while all other ipRGC types by serpin family E member 2 (Serpine2) and cadherin related family member 1 (Cdhr1) (Tran et al, 2019).…”
Section: F-retinal Ganglion Cells (All Subtypes) and Provisionally N-...mentioning
Retinal ganglion cells (RGCs) are a heterogeneous population of neurons that function synchronously to convey visual information through the optic nerve to retinorecipient target areas in the brain. Injury or disease to the optic nerve results in RGC degeneration and loss of visual function, as few RGCs survive, and even fewer can be provoked to regenerate their axons. Despite causative insults being broadly shared, regeneration studies demonstrate that RGC types exhibit differential resilience to injury and undergo selective survival and regeneration of their axons. While most early studies have identified these RGC types based their morphological and physiological characteristics, recent advances in transgenic and gene sequencing technologies have further enabled type identification based on unique molecular features. In this review, we provide an overview of the well characterized RGC types and identify those shown to preferentially survive and regenerate in various regeneration models. Furthermore, we discuss cellular characteristics of both the resilient and susceptible RGC types including the combinatorial expression of different molecular markers that identify these specific populations. Lastly, we discuss potential molecular mechanisms and genes found to be selectively expressed by specific types that may contribute to their reparative capacity. Together, we describe the studies that lay the important groundwork for identifying factors that promote neural regeneration and help advance the development of targeted therapy for the treatment of RGC degeneration as well as neurodegenerative diseases in general.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.